Genetic basis of pancreas cancer development and progression: insights from whole-exome and whole-genome sequencing - Test2 - elhamkhani - TriplyDB

Genetic basis of pancreas cancer development and progression: insights from whole-exome and whole-genome sequencing

Genetic basis of pancreas cancer development and progression: insights from whole-exome and whole-genome sequencing

http://www.wikidata.org/entity/Q26991615

about

Heterogeneity and targeting of pancreatic cancer stem cells Oncolytic viral therapy for pancreatic cancer: current research and future directions Human correlates of provocative questions in pancreatic pathology The pancreas cancer microenvironment Deciphering the link between PI3K and PAK: An opportunity to target key pathways in pancreatic cancer?A rapid in vivo screen for pancreatic ductal adenocarcinoma therapeutics.CHD7 expression predicts survival outcomes in patients with resected pancreatic cancer.Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients Familial and sporadic pancreatic cancer share the same molecular pathogenesis.ERK kinase phosphorylates and destabilizes the tumor suppressor FBW7 in pancreatic cancer RUNX3 Controls a Metastatic Switch in Pancreatic Ductal Adenocarcinoma Role of RHOT1 on migration and proliferation of pancreatic cancer.Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma Specimens.An angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesis.Establishment and characterization of new cell lines of anaplastic pancreatic cancer, which is a rare malignancy: OCUP-A1 and OCUP-A2.PIK3CA mutations can initiate pancreatic tumorigenesis and are targetable with PI3K inhibitors A Phase I Safety, Pharmacokinetic, and Pharmacodynamic Presurgical Trial of Vitamin E δ-tocotrienol in Patients with Pancreatic Ductal Neoplasia A phase 1/2 and biomarker study of preoperative short course chemoradiation with proton beam therapy and capecitabine followed by early surgery for resectable pancreatic ductal adenocarcinoma Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma.Exome-wide single-base substitutions in tissues and derived cell lines of the constitutive Fhit knockout mouse.SnapShot: pancreatic cancer.Second-line treatment in advanced pancreatic cancer: a comprehensive analysis of published clinical trials.Genetic Diversity of Pancreatic Ductal Adenocarcinoma and Opportunities for Precision Medicine Role of abnormal lipid metabolism in development, progression, diagnosis and therapy of pancreatic cancer.Blocking downstream signaling pathways in the context of HDAC inhibition promotes apoptosis preferentially in cells harboring mutant Ras.Conceptual framework for cutting the pancreatic cancer fuel supply.Advanced-stage pancreatic cancer: therapy options.Pathology of pancreatic ductal adenocarcinoma: facts, challenges and future developments.Evolution of targeted therapies in cancer: opportunities and challenges in the clinic.Pancreatic cancer: current understanding of molecular and genetic aetiologies.Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer.Pancreatic Cancer Chemoprevention Translational Workshop: Meeting Report NO• and Pancreatic Cancer: A Complex Interaction with Therapeutic Potential.Endoscopic ultrasound in pancreatic cancer: innovative applications beyond the basics.Cyclic AMP regulates the migration and invasion potential of human pancreatic cancer cells.Analysis of ctDNA to predict prognosis and monitor treatment responses in metastatic pancreatic cancer patients.Regulation of GLI Underlies a Role for BET Bromodomains in Pancreatic Cancer Growth and the Tumor Microenvironment.PCMdb: pancreatic cancer methylation database.Accurate prediction of nodal status in preoperative patients with pancreatic ductal adenocarcinoma using next-gen nanoparticle.KRAS: The Critical Driver and Therapeutic Target for Pancreatic Cancer.

P2860

Q26851734-8B5205B6-0C28-4A2F-B6DF-04AFA3A1969D Q27011439-29591B46-8223-41A6-B9FA-8831BD947E1A Q27023576-8604BA73-4CD6-40C5-A638-BCD38C000AF4 Q27026705-81D37DA3-7B04-4AC0-ADDE-269AAE03CB52 Q28079848-2C398DFE-029E-492C-A118-32F3F3F7EE9A Q30669159-6A025788-3D01-4CD9-8302-A9761723E984 Q33630872-9D1CF95D-2F59-4891-8C50-4D00AA42B3E8 Q34483980-4BC86478-43ED-446A-B08A-046C7825E048 Q35171140-2A430619-A7A6-4913-9272-8F566C7E7606 Q35578938-78D05E99-8420-4DA8-A604-5FF53BF1423F Q35690596-D30B502A-89ED-46C2-A398-A1C54CB7696C Q35758011-BAC62D7C-690C-4FAA-AF5D-00CCC6395393 Q35797487-B5D75EAE-6F2B-48DE-A077-2781E85A0FCF Q35955457-D55C4C56-3EA4-49E4-80CE-EEE5F7BD3DC4 Q35986433-060512F7-6EA9-4385-A54D-EA776922C51A Q36245945-086EF3E1-4D57-4132-B4E8-E983FBE30743 Q36437690-9859D84E-7DCF-404F-8439-84BFF0F66A02 Q36685241-9BBB20A7-CB3C-4B21-ACD4-A6959B83717B Q36772125-700FAB70-9BD9-4ED0-B683-461D951C5CE3 Q36801149-2D109639-DB02-43C8-B982-AD7EC2F3B4CE Q36802728-25A1EAFC-2CB1-4C2D-BBE4-869F7901D981 Q37032865-B2FAF424-43CD-45B3-9374-2C096C3FC280 Q37230991-C8D4666B-DF29-40A4-87A8-826DB1127887 Q37617965-8BB94321-1030-4AFB-827D-CDC9BC657D92 Q37684405-A607F433-B764-410B-B374-1B51963043A9 Q38034956-335A9D94-A12B-46C9-AD20-201695125EE5 Q38102914-452698BF-2D47-4D5F-A264-C2369DD5D69B Q38260683-703E0ACC-E458-47A7-8A78-740D67F7701D Q38319572-6B2A37BD-A7DC-4864-B768-E98BB97A247B Q38540431-BC259AFA-97F1-4748-9D71-5456C7337119 Q38769887-C60B2345-5DF7-4B1A-ACE0-4E4BFB7DB86F Q38831886-8B8FFA95-354C-4AF8-B157-806D02FC4F55 Q38832619-D42FCA19-4F96-40CE-B2A1-1B856C866C37 Q39025906-7047CD5B-359D-467E-BB6A-69197CCB1814 Q39081937-127A9B05-43EF-4E0F-9E81-15312A021110 Q40444196-B28B42FF-0213-46C6-874B-0823BC5B9622 Q41738818-B3AE985C-A1E3-4BF2-8A20-D6FE47C973D2 Q41858336-00354224-B5F8-4E5A-AB29-B3B6408C5D79 Q41869715-CEAE9335-82D4-4FF9-95A9-88D0DB9FBC58 Q47563012-C0C281C7-3DDD-4B26-918A-88262516A0DA

P2860

Genetic basis of pancreas cancer development and progression: insights from whole-exome and whole-genome sequencing

http://www.wikidata.org/entity/Q26991615

description

2012 nî lūn-bûn

@nan

2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Genetic basis of pancreas canc ...... me and whole-genome sequencing

@ast

Genetic basis of pancreas canc ...... me and whole-genome sequencing

@en

Genetic basis of pancreas canc ...... me and whole-genome sequencing

@nl

type

label

Genetic basis of pancreas canc ...... me and whole-genome sequencing

@ast

Genetic basis of pancreas canc ...... me and whole-genome sequencing

@en

Genetic basis of pancreas canc ...... me and whole-genome sequencing

@nl

prefLabel

Genetic basis of pancreas canc ...... me and whole-genome sequencing

@ast

Genetic basis of pancreas canc ...... me and whole-genome sequencing

@en

Genetic basis of pancreas canc ...... me and whole-genome sequencing

@nl

P1433

Q26991615-48A7A848-7CD4-486A-8E10-C65DFCC336B7

P1476

Q26991615-4B28A7BF-31B0-4A97-BC17-4E4207FF0D3D

P2093

Q26991615-B468D81B-F341-41FF-97A2-CF54B1CE4DB9

P2860

Q26991615-009A7A65-1CA4-4ED1-A43C-7AFF91A85DA2

Q26991615-00FBC499-BC64-461E-BB38-682E980F3922

Q26991615-07703A23-C7F8-4102-9EB0-2F01850BA80D

Q26991615-1B071766-A020-4958-825B-C17B48567647

Q26991615-243FDBC5-B9E4-4F52-9AF6-1B1AB7B34D69

Q26991615-2E5FF62F-2DC1-485A-A647-FC047F789FC0

Q26991615-37BB9362-465E-4BD2-B3C0-BFBF528EC22D

Q26991615-410F6185-6206-442F-8EDB-E88BFF314418

Q26991615-424D57EF-8188-41C8-B840-D924B4E9A45C

Q26991615-425827AB-F769-48A8-82E3-2D2537589A29

P304

Q26991615-FF216B4E-863E-4A78-A874-73BD20199C6E

P31

Q26991615-9F452ADF-FD52-4D6D-9EF0-5AF6BBB13973

P3181

Q26991615-29B1E248-4863-4013-8D91-2165CF7E5656

P356

Q26991615-9C810F73-93DE-41DF-8086-9DE4F9677C9A

P407

Q26991615-13D0CBFF-6123-4924-B2FB-66B468E0F02B

P433

Q26991615-4CFF3718-B3CE-4BBD-9E13-05B376EDEC4F

P478

Q26991615-A425F42E-5310-4BBC-B43E-AD6F02548694

P50

Q26991615-26046183-0769-4179-9BBF-87273E7C7EFF

Q26991615-382468E9-D4FE-4E1D-A83C-23F9735B1578

Q26991615-E4282A62-3435-499C-A819-69D3CD9DB228

P577

Q26991615-C3AAD41E-E8A5-4FED-A35F-A093D6B7316C

P698

Q26991615-0F1311EC-AF73-4BC7-8F64-BC817235F734

P921

Q26991615-DC4C1D52-CACC-4CB9-8113-1DFEF469C363

P932

Q26991615-37344259-ABBA-461E-A7DD-0E8CDCCAED1B

P3181

P356

1078-0432.CCR-12-0315

P1433

Clinical Cancer Research

P1476

Genetic basis of pancreas canc ...... me and whole-genome sequencing

@en

P2093

Christopher L Wolfgang

http://www.w3.org/2001/XMLSchema#string

P2860

Core signaling pathways in human pancreatic cancers revealed by global genomic analyses

International network of cancer genome projects.

Distant metastasis occurs late during the genetic evolution of pancreatic cancer

Aberrant MicroRNA-155 expression is an early event in the multistep progression of pancreatic adenocarcinoma

Prevalence of unsuspected pancreatic cysts on MDCT

Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene

Heterogeneity and targeting of pancreatic cancer stem cells

The pancreas cancer microenvironment

DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer.

Personalizing cancer treatment in the age of global genomic analyses: PALB2 gene mutations and the response to DNA damaging agents in pancreatic cancer.

P304

4257-4265

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2387685

http://www.w3.org/2001/XMLSchema#string

P356

10.1158/1078-0432.CCR-12-0315

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

Ralph H. Hruban

Christine A Iacobuzio-Donahue

Victor Velculescu

P577

2012-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22896692

http://www.w3.org/2001/XMLSchema#string

P921

Aizkuņģa dziedzeris

P932

3422771

http://www.w3.org/2001/XMLSchema#string